Skip to content

The effects of probiotic yoghurt on type 2 diabetes

The effects of consumption of probiotic yoghurt and conventional yoghurt on blood sugar, lipid profile, oxidative stress parameters and inflammatory marker in type 2 diabetic patients.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT138903223533N1
Enrollment
60
Registered
2010-07-03
Start date
2010-05-31
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes. Non-insulin-dependent diabetes mellitus

Interventions

Placebo
Intervention Group:Probiotic Yoghurt,300 gr/day,6 weeks
Control Group:Conventional Yoghurt,300 gr/day,6 weeks
Intervention 1: Intervention Group:Probiotic Yoghurt,300 gr/day,6 weeks. Intervention 2: Control Group:Conventional Yoghurt,300 gr/day,6 weeks.
Treatment - Drugs

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor
Iran Dairy Industries Company
Collaborator

Eligibility

Sex/Gender
All
Age
30 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: having type 2 diabetes, 30 to 60 years old, LDL level more than 100 mg/Dl Exclusion criteria: having the renal or hepatic failure, cardiovascular disease, inflammatory bowel disease, thyroid disorders and lactose intolerance, treatment with insulin and taking corticosteroids, NSAIDS, immunosuppressives, cholesterol lowering drugs, multivitamin-mineral and fiber supplements, BMI more than 35 Kg/m2, smoking, pregnancy and lactation, use of multivitamin-mineral and fiber supplements 3 weeks prior to the study, use of antibiotics 1 month the study and during the study, having acute gastrointestinal disorders 1 month prior to the study and during the study

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
HsCRP. Timepoint: baseline and after 6 weeks. Method of measurement: immunotorbidometry.;Fasting Blood Sugar. Timepoint: baseline and after 6 weeks. Method of measurement: spectrophotometry.;Hemoglobin A1c. Timepoint: baseline and after 6 weeks. Method of measurement: Chromatography.;Insulin. Timepoint: baseline and after 6 weeks. Method of measurement: ELIZA.;HOMA-IR. Timepoint: Baseline and after 6 weeks. Method of measurement: Formula.;Total Cholesterol. Timepoint: Baseline and after 6 weeks. Method of measurement: Spectrophotometry.;Triglyceride. Timepoint: Baseline and after 6 weeks. Method of measurement: Spectrophotometry.;HDL. Timepoint: Baseline and after 6 weeks. Method of measurement: Spectrophotometry.;LDL. Timepoint: Baseline and after 6 weeks. Method of measurement: Friedewald Formula.;Malondialdehyde. Timepoint: Baseline and after 6 weeks. Method of measurement: Spectrophotometry.;Catalase. Timepoint: Baseline and after 6 weeks. Method of measurement: Hugo Aebi Method.;Glutathione peroxidase. Timepoint: Baseline and after 6 weeks. Method of measurement: Spectrophotometry.;Superoxide dismutase. Timepoint: Baseline and after 6 weeks. Method of measurement: Spectrophotometry.;Total Antioxidant Capacity (TAC). Timepoint: Baseline and after 6 weeks. Method of measurement: Spectrophotometry.

Secondary

MeasureTime frame
Body Mass Index. Timepoint: Baseline and after 6 weeks. Method of measurement: Formula.;Dietary Factors. Timepoint: Baseline and after 6 weeks. Method of measurement: 3-day 24h dietary recalls.;Blood Pressure. Timepoint: Baseline and after 6 weeks. Method of measurement: Sphygmomanometer.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Javad Mohtadi Nia

Faculty of Health and Nutrition, Tabriz University of Medical Sciences

Mohtadiniaj@tbzmed.ac.ir,Haniejtahed@yahoo.com+98 41 1335 7580

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026